Mesleki maruziyet nedeni ile alüminyum intoksikasyonu olan olguda gelişen polinöropati ve Alzheimer hastalığı: Olgu sunumu

Yıl 2018, Cilt: 4 Sayı: 4, 191 - 193, 03.01.2019

Damla Çağla Patır , Harun Akar

Öz

Alzheimer hastalığı zamanla kademeli olarak bozulan ilerleyici bir nörodejeneratif hastalıktır. Hastalık ilerledikçe, bilişsel beceriler, karar verme yetisi ve günlük işleri yürütme becerisi önemli derecede azalır. Alüminyum, Alzheimer hastalığının etyolojisinde yer aldığı kanıtlanmış nörotoksik bir ajandır. Bu yazıda, mesleki maruziyet nedeni ile alüminyum intoksikasyonu gelişen ve demans ve polinöropati bulguları ile tarafımıza başvuran bir olgu sunuldu.

Anahtar Kelimeler

Alüminyum intoksikasyonu, Alzheimer hastalığı, Meslek hastalıkları

Kaynakça

• 1. Singh NA, Mandal AK, Khan ZA. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG). Nutr J 2016;15:60.
• 2. Thal DR, Fändrich M. Protein aggregation in Alzheimer's disease: Ab and t and their potential roles in the pathogenesis of AD. Acta Neuropathol 2015;129:163-5.
• 3. Cam JA, Bu G. Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family. Mol Neurodegener 200618;1:8.
• 4. Kimura R, Ohno M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis 2009;33:229-35.
• 5. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002;297:353-6.
• 6. Sun ZZ, Chen ZB, Jiang H, Li LL, Li EG, Xu Y. Alteration of Ab metabolism-related molecules in predementia induced by AlCl3 and D-galactose. Age (Dordr) 2009;31:277-84.
• 7. Flaten TP. Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res Bull 2001;55:187-96.
• 8. Prema A, Justin Thenmozhi A, Manivasagam T, Mohamed Essa M, Guillemin GJ. Fenugreek seed powder attenuated aluminum chloride-induced tau pathology, oxidative stress, and inflammation in a rat model of Alzheimer’s Disease. J Alzheimers Dis 2017;60:209-20.
• 9. Pavlik VN, Doody RS, Massman PJ, Chan W. Influence of premorbid IQ and education on progression of Alzheimer’s disease. Dement Geriatr Cogn Disord 2006;22:367-77.
• 10. Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF. Aluminum and silica in drinking water and the risk of Alzheimer’s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol 2009;169:489-96.
• 11. Roskams AJ, Connor JR. Aluminum access to the brain: a role for transferrin and its receptor. Proc Natl Acad Sci USA 1990;87:9024-7.
• 12. Giorgianni CM, D’Arrigo G, Brecciaroli R, Abbate A, Spatari G, Tringali MA, et al. Neurocognitive effects in welders exposed to aluminium. Toxicol Ind Health 2014;30:347-56.
• 13. Akila R, Stollery BT, Riihimäki V. Decrements in cognitive performance in metal inert gas welders exposed to aluminium. Occup Environ Med 1999;56:632-9.
• 14. Kiesswetter E, Schäper M, Buchta M, Schaller KH, Rossbach B, Scherhag H, et al. Longitudinal study on potential neurotoxic effects of aluminium: I. Assessment of exposure and neurobehavioural performance of Al welders in the train and truck construction industry over 4 years. Int Arch Occup Environ Health 2007;81:41-67.
• 15. Buchta AM, Kiesswetter BE, Schäper BM, Zschiesche CW, Schaller D KH, Kuhlmann AA, et al. Neurotoxicity of exposures to aluminium welding fumes in the truck trailer construction industry. Environ Toxicol Pharmacol 2005;19:677-85.
• 16. Altmann P, Dhanesha U, Hamon C, Cunningham J, Blair J, Marsh F. Disturbance of cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity. Lancet 1989;2:7-12.
• 17. Bolla KI, Milstien S, Briefel G, Wieler L, Kaufman S. Dihydropteridine reductase activity: lack of association with serum aluminum levels and cognitive functioning in patients with end-stage renal disease. Neurology 1991;41:1806-9.
• 18. Jackson M, Warrington EK, Roe CJ, Baker LR. Cognitive function in hemodialysis patients. Clin Nephrol 1987;27:26-30.
• 19. Exley C, Mamutse G, Korchazhkina O, Pye E, Strekopytov S, Polwart A, et al. Elevated urinary excretion of aluminium and iron in multiple sclerosis. Mult Scler 2006;12:533-40.
• 20. Kawahara M. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis 2005;8:171-82.
• 21. Bansal VK, Bansal S. Nervous system disorders in dialysis patients. Handb Clin Neurol 2014;119:395-404.
• 22. Laabdar W, Elgot A, Gamrani H. The protective effect of curcumin on dopaminergic system after chronic aluminium intoxication: Possible link with Parkinson’s disease. Parkinsonism Relat Disord 2016;22:e188.
• 23. Kawahara M, Kato-Negishi M. Link between aluminum and the pathogenesis of Alzheimer's disease: The integration of the aluminum and amyloid cascade hypotheses. Int J Alzheimers Dis 2011;2011:276393.